100 related articles for article (PubMed ID: 25589778)
1. Prescription opioids. III. Disposition of oxycodone in oral fluid and blood following controlled single-dose administration.
Cone EJ; DePriest AZ; Heltsley R; Black DL; Mitchell JM; LoDico C; Flegel R
J Anal Toxicol; 2015 Apr; 39(3):192-202. PubMed ID: 25589778
[TBL] [Abstract][Full Text] [Related]
2. Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration.
Cone EJ; Heltsley R; Black DL; Mitchell JM; Lodico CP; Flegel RR
J Anal Toxicol; 2013 Jun; 37(5):255-64. PubMed ID: 23609023
[TBL] [Abstract][Full Text] [Related]
3. Prescription Opioids. V. Metabolism and Excretion of Oxymorphone in Urine Following Controlled Single Dose Administration.
DePriest AZ; Heltsley R; Black DL; Mitchell JM; LoDico C; Flegel R; Cone EJ
J Anal Toxicol; 2016 Oct; 40(8):566-574. PubMed ID: 27405370
[TBL] [Abstract][Full Text] [Related]
4. Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration.
Cone EJ; DePriest AZ; Heltsley R; Black DL; Mitchell JM; LoDico C; Flegel R
J Anal Toxicol; 2015 Sep; 39(7):510-8. PubMed ID: 25962610
[TBL] [Abstract][Full Text] [Related]
5. Oxycodone Concentrations and Metabolic Ratios in Femoral Blood from Fatal Intoxications and Other Causes of Death using LC-MS-MS.
Jakobsson G; Gréen H; Kronstrand R
J Anal Toxicol; 2021 Feb; 45(2):124-133. PubMed ID: 32435814
[TBL] [Abstract][Full Text] [Related]
6. Pooled post hoc analysis of population pharmacokinetics of oxycodone and acetaminophen following a single oral dose of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets.
Franke RM; Morton T; Devarakonda K
Drug Des Devel Ther; 2015; 9():4587-97. PubMed ID: 26316698
[TBL] [Abstract][Full Text] [Related]
7. Prescription opioids. II. Metabolism and excretion patterns of hydrocodone in urine following controlled single-dose administration.
Cone EJ; Heltsley R; Black DL; Mitchell JM; Lodico CP; Flegel RR
J Anal Toxicol; 2013 Oct; 37(8):486-94. PubMed ID: 23946451
[TBL] [Abstract][Full Text] [Related]
8. Interpretation of oxycodone concentrations in oral fluid.
Moore C; Kelley-Baker T; Lacey J
J Opioid Manag; 2012; 8(3):161-6. PubMed ID: 22798176
[TBL] [Abstract][Full Text] [Related]
9. The Quantification of Oxycodone and Its Phase I and II Metabolites in Urine.
Truver MT; Jakobsson G; Chermà MD; Swortwood MJ; Gréen H; Kronstrand R
J Anal Toxicol; 2022 Feb; 46(1):55-63. PubMed ID: 33270113
[TBL] [Abstract][Full Text] [Related]
10. Development of a Quantitative LC-MS-MS Assay for Codeine, Morphine, 6-Acetylmorphine, Hydrocodone, Hydromorphone, Oxycodone and Oxymorphone in Neat Oral Fluid.
Grabenauer M; Moore KN; Bynum ND; White RM; Mitchell JM; Hayes ED; Flegel R
J Anal Toxicol; 2018 Jul; 42(6):392-399. PubMed ID: 29554298
[TBL] [Abstract][Full Text] [Related]
11. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
Boström E; Jansson B; Hammarlund-Udenaes M; Simonsson US
Rapid Commun Mass Spectrom; 2004; 18(21):2565-76. PubMed ID: 15468158
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
Chan S; Edwards SR; Wyse BD; Smith MT
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
[TBL] [Abstract][Full Text] [Related]
13. Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry.
Neuvonen M; Neuvonen PJ
Ther Drug Monit; 2008 Jun; 30(3):333-40. PubMed ID: 18520605
[TBL] [Abstract][Full Text] [Related]
14. Prescription Opioids. VI. Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration.
DePriest AZ; Heltsley R; Black DL; Mitchell JM; LoDico C; Flegel R; Cone EJ
J Anal Toxicol; 2016 Oct; 40(8):575-582. PubMed ID: 27405368
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.
Kaiko RF; Benziger DP; Fitzmartin RD; Burke BE; Reder RF; Goldenheim PD
Clin Pharmacol Ther; 1996 Jan; 59(1):52-61. PubMed ID: 8549034
[TBL] [Abstract][Full Text] [Related]
16. Disposition of opioids in oral fluid: Importance of chromatography and mass spectral transitions in LC-MS/MS.
Tuyay J; Coulter C; Rodrigues W; Moore C
Drug Test Anal; 2012 Jun; 4(6):395-401. PubMed ID: 22374679
[TBL] [Abstract][Full Text] [Related]
17. The Disposition of Oxycodone and Metabolite in Human Hair.
Reisfield GM; Jones JT
J Anal Toxicol; 2015; 39(9):746-50. PubMed ID: 26178162
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and Disposition of Prescription Opioids: A Review.
DePriest AZ; Puet BL; Holt AC; Roberts A; Cone EJ
Forensic Sci Rev; 2015 Jul; 27(2):115-45. PubMed ID: 26227254
[TBL] [Abstract][Full Text] [Related]
19. Grapefruit juice enhances the exposure to oral oxycodone.
Nieminen TH; Hagelberg NM; Saari TI; Neuvonen M; Neuvonen PJ; Laine K; Olkkola KT
Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):782-8. PubMed ID: 20406214
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo assessment of the abuse potential of PF614, a novel BIO-MD™ prodrug of oxycodone.
Kirkpatrick DL; Schmidt WK; Morales R; Cremin J; Seroogy J; Husfeld C; Jenkins T
J Opioid Manag; 2017; 13(1):39-49. PubMed ID: 28345745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
